Leiden-based Amarna Therapeutics announces the appointment of Dr Henk Streefkerk as the company’s new Chief Executive Officer and Medical Director. Streefkerk has already been Amarna’s Medical Director since mid-2022.
https://european-biotechnology.com/wp-content/uploads/2024/04/EB.com_Henk__Streefkerk_Amarna__Therapeutics_kl..jpeg15481377Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-06-07 15:22:142024-07-16 17:01:35Amarna Therapeutics appoints new CEO